Anti-HIRA (Histone Cell Cycle Regulation Defective Homolog A, TUPLE1, TUP1-like Enhancer of Split Pr

Anti-HIRA (Histone Cell Cycle Regulation Defective Homolog A, TUPLE1, TUP1-like Enhancer of Split Pr
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
137442.100 100 µl - -

3 - 19 Werktage*

778,00 €
 
Histone cell cycle regulation defective homolog A (HIRA), also known as TUP1-like enhancer of... mehr
Produktinformationen "Anti-HIRA (Histone Cell Cycle Regulation Defective Homolog A, TUPLE1, TUP1-like Enhancer of Split Pr"
Histone cell cycle regulation defective homolog A (HIRA), also known as TUP1-like enhancer of split protein 1 (TUPLE1), is the mammalian homolog of the yeast HIR1 and HIR2 transcriptional repressor proteins (1). HIRA interacts with UBN1, CABIN, and ASF1A in the cell nucleus to form the evolutionarily conserved HUCA histone chaperone complex that deposits the variant histone H3.3 into chromatin in a DNA-replication independent manner (2). HIRA is required for deposition of histone H3.3 at the transcription start sites of genes, where incorporation of histone H3.3 facilitates nucleosome destabilization and contributes to transcriptional activation (3-5). Histone H3.3 is also linked to gene silencing and is incorporated into regions of the genome thought to be transcriptionally inactive (5-7). While some incorporation of H3.3 into heterochromatin is facilitated by an additional histone chaperone complex containing ATRX and DAXX (ie. telomeric incorporation of H3.3), HIRA is required for incorporation of histone H3.3 and formation of senescence-associated heterochromatin foci (SAHF) during cellular senescence (5-8). HIRA is ubiquitously expressed during mouse embryonic development (9). In the adult mouse, HIRA is expressed at high levels in the kidney, skeletal muscle, and pancreas, but it is expressed at lower levels in the heart, lung, placenta, brain, and liver (9). A missing copy of the HIRA gene on human chromosome region 22q11.2 is a common characteristic of DiGeorge syndrome patients and insufficient production of the HIRA protein may disrupt normal embryonic development (9). Applications: Suitable for use in Western Blot and Immunoprecipitation. Other applications not tested. Recommended Dilution: Western Blot: 1:1000. Incubate membrane with diluted antibody in 5% w/v nonfat dry milk, 1X TBS, 0.1% Tween-20 at 4°C with gentle shaking, overnight., Immunoprecipitation: 1:50, Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Hersteller: United States Biological
Hersteller-Nr: 137442

Eigenschaften

Anwendung: IP, WB
Antikörper-Typ: Monoclonal
Klon: 13G35(D6O8L)
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human, monkey, mouse, rat
Immunogen: Recombinant protein corresponding to the C-terminal domain of human HIRA.
Format: Purified

Handhabung & Sicherheit

Lagerung: -20°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-HIRA (Histone Cell Cycle Regulation Defective Homolog A, TUPLE1, TUP1-like Enhancer of Split Pr"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen